Anti-melanoma Effects of Resiquimod (RSQ) In Vitro and in Combination with Immune Checkpoint Blockade In Vivo

Overview of attention for article published in The AAPS Journal, June 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter: 3 X users

patent: 1 patent

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 1,427 followers.

Anti-melanoma Effects of Resiquimod (RSQ) In Vitro and in Combination with Immune Checkpoint Blockade In Vivo. https://t.co/eO4QEmqH1U https://t.co/l2778zbbS8

SharedIt link for free access: https://t.co/pgYGG2n67c

In press: Anti-melanoma Effects of Resiquimod (RSQ) In Vitro and in Combination with Immune Checkpoint Blockade In Vivo. @theaapsjournal . Supreeda Tambunlertchai, Sean M. Geary, Youssef Naguib & Aliasger K. Salem. https://t.co/k31Er3EFdK

Anti-melanoma Effects of Resiquimod (RSQ) In Vitro and in Combination with Immune Checkpoint Blockade In Vivo https://t.co/nTXnyAbVGT https://t.co/pRvnnGnTqo

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.